Xiaobin Guo
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Surgery 18
- Orthopaedic implants and arthroplasty 13
- Orthopedic Infections and Treatments 9
- Total Knee Arthroplasty Outcomes 5
-
- Bone Metabolism and Diseases 6
- Extracellular vesicles in disease 4
- Co-authors
- Dechun Geng (15 shared papers)Yu Liu (14 shared papers)Jiaxiang Bai (15 shared papers)Yaozeng Xu (12 shared papers)Wei Zhou (8 shared papers)Xiexing Wu (7 shared papers)Zhirong Wang (7 shared papers)Jiawei Shi (7 shared papers)
- Journals
- Acta Biomaterialia (3 papers)The Journal of Arthroplasty (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Cell Death and Disease (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaobin Guo
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 110
- Geriatrics and Gerontology 74
- Cancer Research 203
- Orthopedics and Sports Medicine 111
- Endocrine and Autonomic Systems 72
- Rheumatology 157
Countries citing papers authored by Xiaobin Guo
This map shows the geographic impact of Xiaobin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Guo more than expected).
Fields of papers citing papers by Xiaobin Guo
This network shows the impact of papers produced by Xiaobin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Guo. The network helps show where Xiaobin Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 111 | |
| 2 | 2017 | 96 | |
| 3 | 2017 | 70 | |
| 4 | 2019 | 67 | |
| 5 | 2019 | 62 | |
| 6 | 2018 | 59 | |
| 7 | 2016 | 59 | |
| 8 | 2018 | 46 | |
| 9 | 2017 | 44 | |
| 10 | 2021 | 44 | |
| 11 | 2018 | 41 | |
| 12 | 2016 | 38 | |
| 13 | 2019 | 34 | |
| 14 | 2017 | 33 | |
| 15 | 2017 | 33 | |
| 16 | AKIP1 promoted epithelial-mesenchymal transition of non-small-cell lung cancer via transactivating ZEB1. | 2017 | 30 |
| 17 | 2018 | 28 | |
| 18 | 2017 | 24 | |
| 19 | 2019 | 22 | |
| 20 | 2019 | 22 |
About Xiaobin Guo
Xiaobin Guo is a scholar working on Surgery, Molecular Biology, Pharmacology, Oncology and Cardiology and Cardiovascular Medicine, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Orthopaedic implants and arthroplasty (13 papers), Orthopedic Infections and Treatments (9 papers), Bone Metabolism and Diseases (6 papers), Total Knee Arthroplasty Outcomes (5 papers), Bone Tissue Engineering Materials (4 papers), Extracellular vesicles in disease (4 papers), Sirtuins and Resveratrol in Medicine (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Geriatrics and Gerontology (74 citations), Cancer Research (203 citations), Orthopedics and Sports Medicine (111 citations), Endocrine and Autonomic Systems (72 citations) and Rheumatology (157 citations). Xiaobin Guo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Dechun Geng, Yu Liu, Jiaxiang Bai, Yaozeng Xu, Wei Zhou, Xiexing Wu, Zhirong Wang, Jiawei Shi, Jiayi Lin and Wen Zhang. Their work appears in journals such as Acta Biomaterialia, The Journal of Arthroplasty, Oxidative Medicine and Cellular Longevity, Cell Death and Disease and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.